找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Recombinant Protein Drugs; Peter Buckel Book 2001 Birkh?user Verlag 2001 clinic.clinical trial.development.drug.drug discovery.drugs.futur

[復(fù)制鏈接]
查看: 36748|回復(fù): 42
樓主
發(fā)表于 2025-3-21 17:04:44 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Recombinant Protein Drugs
編輯Peter Buckel
視頻videohttp://file.papertrans.cn/825/824097/824097.mp4
叢書名稱Milestones in Drug Therapy
圖書封面Titlebook: Recombinant Protein Drugs;  Peter Buckel Book 2001 Birkh?user Verlag 2001 clinic.clinical trial.development.drug.drug discovery.drugs.futur
描述Recombinant protein drugs are intimately associated with the impressive success story of the Biotech Industry during the past thirty years, some of them belonging to the most successful pharmaceutical products. More than thirty different proteins are available for a variety of clinical applications, over 300 proteins are presently being evaluated in clinical trials. In this new volume of the MDT series, historical, technical and clinical aspects of recombinant protein drug discovery and development are presented, covering past, present and future highlights. Leading scientists and co-founders of early Biotech companies describe technical breakthroughs and the fascinating story of pioneering discoveries, as well as the long way of translating them into products and business. Therefore, this book represents an exciting documentation of the beginning of a new era in the pharmaceutical industry. In addition, scientists from basic research, clinic and industry actively involved in new developments discuss...
出版日期Book 2001
關(guān)鍵詞clinic; clinical trial; development; drug; drug discovery; drugs; future; gene therapy; hepatitis; interferon
版次1
doihttps://doi.org/10.1007/978-3-0348-8346-7
isbn_softcover978-3-0348-9527-9
isbn_ebook978-3-0348-8346-7Series ISSN 2296-6056 Series E-ISSN 2296-6064
issn_series 2296-6056
copyrightBirkh?user Verlag 2001
The information of publication is updating

書目名稱Recombinant Protein Drugs影響因子(影響力)




書目名稱Recombinant Protein Drugs影響因子(影響力)學(xué)科排名




書目名稱Recombinant Protein Drugs網(wǎng)絡(luò)公開度




書目名稱Recombinant Protein Drugs網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Recombinant Protein Drugs被引頻次




書目名稱Recombinant Protein Drugs被引頻次學(xué)科排名




書目名稱Recombinant Protein Drugs年度引用




書目名稱Recombinant Protein Drugs年度引用學(xué)科排名




書目名稱Recombinant Protein Drugs讀者反饋




書目名稱Recombinant Protein Drugs讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:57:08 | 只看該作者
lead to other problems. For example, if the compressor “l(fā)ocks-up”, the belt which connects the compressor to the engine may break and get caught in some of the moving parts of the engine. In essence, the importance of the compressor to the air conditioning system is like that of the heart to the hum
板凳
發(fā)表于 2025-3-22 03:46:31 | 只看該作者
地板
發(fā)表于 2025-3-22 06:22:09 | 只看該作者
Peter Hans Hofschneider,Kenneth Murrayons by the human operators. During the teaching mode, operation details are stored for future repetitive replays. Since human intervention is required, system autonomy is reduced. The other approach involves the use of textual programming. A system is given the assembly plan in terms of operation de
5#
發(fā)表于 2025-3-22 12:14:30 | 只看該作者
6#
發(fā)表于 2025-3-22 13:47:44 | 只看該作者
7#
發(fā)表于 2025-3-22 17:45:43 | 只看該作者
8#
發(fā)表于 2025-3-22 23:40:30 | 只看該作者
Theodore Friedmannticipate and eliminate high risk or high cost production problems. The key to successful implementation of a producibility engineering program is a management committment to the allocation of sufficient resources to insure that design concepts have been subjected to thorough analyses before the desi
9#
發(fā)表于 2025-3-23 04:12:30 | 只看該作者
10#
發(fā)表于 2025-3-23 06:15:48 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 12:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
阿克陶县| 子长县| 烟台市| 长乐市| 阳信县| 彭水| 安溪县| 梅州市| 芦山县| 紫金县| 大渡口区| 越西县| 谢通门县| 盈江县| 千阳县| 黄梅县| 永春县| 临泉县| 青河县| 保靖县| 嘉定区| 土默特右旗| 邢台市| 犍为县| 安义县| 黔西| 福建省| 竹山县| 共和县| 青浦区| 将乐县| 涪陵区| 托克托县| 红河县| 达拉特旗| 榆社县| 兴化市| 涡阳县| 扎鲁特旗| 喜德县| 双峰县|